reglab/housing_qa huggingface dataset:
TN Code § 68-5-110 (2021)
2021 Tennessee Code|Title 68 - Health, Safety and Environmental Protection|Chapter 5 - Prevention of Diseases|Part 1 - General Provisions|§ 68-5-110. Information on Pertussis Vaccine

 In accordance with the latest recommendations of the advisory committee on immunization practices of the centers for disease control and prevention, during the postpartum period and prior to discharge, each hospital shall provide parents of newborns educational information on pertussis disease and the availability of a vaccine to protect against pertussis. This educational information shall include, but is not limited to, information on the center for disease control and prevention's recommendation that parents and caregivers receive Tdap during the postpartum period to protect their newborns from the transmission of pertussis. Nothing in this section shall require any hospital to provide or pay for any vaccination against pertussis. This section also shall not constitute a requirement to be assessed during any inspection under chapter 11, part 2 of this title.
TN Code § 68-5-111 (2021)
2021 Tennessee Code|Title 68 - Health, Safety and Environmental Protection|Chapter 5 - Prevention of Diseases|Part 1 - General Provisions|§ 68-5-111. Educational Information on Influenza and Availability of Vaccine

  In accordance with the latest recommendations of the advisory committee on immunization practices of the centers for disease control and prevention, each hospital shall between the dates of August 1 through March 31 and prior to patient discharge, provide to patients or inform patients where they can find educational information on influenza disease and the availability of a vaccine to protect against the influenza virus. The educational information shall include, but is not limited to, the causes and symptoms of influenza disease, the effectiveness and known contraindications of influenza immunizations and the means by which influenza is spread. This information shall be provided to all patients aged six (6) months and older and may be provided to a parent or legal guardian of patients aged six (6) months through eighteen (18) years of age.   Nothing in this section shall require any hospital to provide or pay for any vaccination against influenza.   This section shall also not constitute a requirement to be assessed during any inspection under chapter 11, part 2 of this title.
TN Code § 68-5-112 (2021)
2021 Tennessee Code|Title 68 - Health, Safety and Environmental Protection|Chapter 5 - Prevention of Diseases|Part 1 - General Provisions|§ 68-5-112. Making Available Information and Instruction Concerning the Appropriate Use and Techniques of Infant Cardiopulmonary Resuscitation (Cpr) — Blakeleigh Rone Act

  An obstetrical provider who treats a prenatal patient on at least two (2) different occasions shall make available information and instruction concerning the appropriate use and techniques of infant cardiopulmonary resuscitation (CPR) to at least one (1) future parent or caregiver.   A hospital or birthing center where a baby is born shall make available information and instruction concerning the appropriate use and techniques of infant CPR to at least one (1) parent or caregiver before the newborn is discharged from the facility.   A primary care provider who treats a newborn in an ambulatory care setting within twenty-eight (28) days after the date of birth shall make available information and instruction concerning the appropriate use and techniques of infant CPR to at least one (1) parent or caregiver.   Nothing in this section shall require classes in certification of infant CPR. This section shall also not constitute a requirement to be assessed during any inspection under chapter 11, part 2 of this title.   Any facility or practitioner acting within the scope of their licensure or practice shall be immune from any civil or administrative liability under this section and shall have an affirmative defense to any criminal liability arising from making such information available.   This section shall be known and may be cited as the “Blakeleigh Rone Act.”
TN Code § 68-5-113 (2021)
2021 Tennessee Code|Title 68 - Health, Safety and Environmental Protection|Chapter 5 - Prevention of Diseases|Part 1 - General Provisions|§ 68-5-113. Cytomegalovirus — Information — Liability

  As used in this section, “CMV” means cytomegalovirus.   If a healthcare provider as defined by § 63-6-703, who assumes responsibility for the prenatal care of either pregnant women during gestation or women who may become pregnant, has determined that a patient is at risk of contracting CMV, the healthcare provider or the healthcare provider's facility shall inform that patient regarding:  The incidence of CMV;   The transmission of CMV to at-risk women who are pregnant or who may become pregnant;   Birth defects caused by congenital CMV;   Methods of diagnosing congenital CMV; and   Available preventative measures.     Healthcare providers covered under subsection (b) are encouraged to provide all other patients with information identifying where the patients can learn about CMV.    Nothing in this section shall be construed to create or impose liability for failing to comply with the requirements of this section.   Nothing in this section shall be deemed to create a duty of care or other legal obligation beyond the requirements set forth in this section.
TN Code § 68-5-114 (2021)
2021 Tennessee Code|Title 68 - Health, Safety and Environmental Protection|Chapter 5 - Prevention of Diseases|Part 1 - General Provisions|§ 68-5-114. Chronic Disease Prevention Act

  This section shall be known and may be cited as the “Chronic Disease Prevention Act.”   By no later than October 1, 2019, the speaker of the senate, the speaker of the house of representatives, the commissioner of health, and the governor shall establish a task force to study methods on how best to prevent cardiovascular disease, hypertension, and diabetes in this state.   The task force is composed of eleven (11) members, as follows:  One (1) member of the senate health and welfare committee, to be appointed by the speaker of the senate;   One (1) member of the health committee of the house of representatives, to be appointed by the speaker of the house of representatives;   One (1) member of the senate finance, ways and means committee, to be appointed by the speaker of the senate;   One (1) member of the house finance, ways and means committee, to be appointed by the speaker of the house of representatives;   One (1) member of the senate who serves in a leadership position, to be appointed by the speaker of the senate;   One (1) member of the house of representatives who serves in a leadership position, to be appointed by the speaker of the house of representatives;   Three (3) persons who are subject matter experts in one (1) or more of the subjects that the task force will study, to be appointed by the governor in consultation with the commissioner of health;   One (1) person who is a certified medical professional from a historically black college or university offering advanced degrees in medicine, dentistry, or public health administration based in Tennessee and having a research and development unit, to be appointed by the governor; and   One (1) person who possesses experience in the subjects of health and public health and who has previous legislative experience, to be appointed by the governor.     The person appointed under subdivision (c)(9) shall call the first meeting of the task force.   By no later than December 15, 2020, the task force shall complete its findings and make recommendations in a report to the governor and to the speaker of the senate and the speaker of the house of representatives.   The members of the task force shall serve without compensation but are entitled to reimbursement of any travel expenses incurred. All reimbursement for travel expenses must conform to the comprehensive state travel regulations as promulgated by the commissioner of finance and administration and approved by the attorney general and reporter.   The task force ceases to exist upon completion of the task force's report and recommendations.
TN Code § 68-5-202 (2021)
2021 Tennessee Code|Title 68 - Health, Safety and Environmental Protection|Chapter 5 - Prevention of Diseases|Part 2 - Newborn Testing — Eyes|§ 68-5-202. Treatment Specified for Infant at Birth — Reports of Redness, Swelling, Inflammation or Pus — Religious Exemption

  It is the duty of any physician, nurse or midwife who assists and is in charge at the birth of any infant, or has the care of the infant after birth, to treat the eyes of the infant with a prophylaxis to prevent ophthalmia neonatorum or infections leading to blindness. The treatment shall be given as soon as practicable after the birth of the infant and always within one (1) hour; and if any redness, swelling, inflammation, or gathering of pus appears in the eyes of the infant or upon the lid or about the eyes within two (2) weeks after birth, then any nurse, midwife or other person having care of the infant shall report the condition within six (6) hours after its discovery to a physician licensed and practicing medicine in this state.   Nothing in this part shall require medical treatment under subsection (a) for the minor child of any person who files with the department of health a signed, written statement that such medical treatment conflicts with the person's religious tenets and practices, affirmed under penalties of perjury.
TN Code § 68-5-401 (2021)
2021 Tennessee Code|Title 68 - Health, Safety and Environmental Protection|Chapter 5 - Prevention of Diseases|Part 4 - Newborn Testing — Metabolic Defects|§ 68-5-401. Testing Required — Public Policy

   The general assembly declares that, as a matter of public policy of this state and in the interest of public health, every newborn infant shall be tested for phenylketonuria, hypothyroidism, galactosemia and other metabolic/genetic defects that would result in intellectual disability or physical dysfunction as determined by the department, through rules and regulations duly promulgated in accordance with the Uniform Administrative Procedures Act, compiled in title 4, chapter 5, and that the people of this state shall be extensively informed as to the nature and effects of such defects.   Every provider of prenatal care will adhere to the American College of Obstetricians and Gynecologists and the Centers for Disease Control recommendations for the prevention of Perinatal Group B Streptococcal Disease.   All infants born in this state shall be tested for specific genetic, metabolic, or other heritable conditions beginning six (6) months following the occurrence of all of the following:  The development of a reliable test or series of tests for screening newborns for specific genetic, metabolic, or other heritable conditions using dried blood spots or other testing and quality assurance testing methodology for such specific genetic, metabolic or the heritable conditions testing;   The availability of quality assurance materials for the specific genetic, metabolic, or other heritable condition tests from the federal centers for disease control and prevention;   The review and approval of the proposed test by the genetics advisory committee of the department of health; and   The acquisition of necessary equipment, completion of appropriate validation tests, and hiring of any necessary staff to implement the expanded screening tests by the newborn screening laboratory and newborn screening follow-up program of the state.     The department of health may charge a reasonable fee and any reasonable increase in this fee, as necessary, for the test performed pursuant to this section. The amount of the fee and the procedures for collecting the fee shall be determined by the commissioner of health.     If the department levies a fee or charge for the cost of testing, it shall use the same billing and collection methods normally used by independent private laboratories. Any fee shall be waived for patients who are unable to pay.
TN Code § 68-5-402 (2021)
2021 Tennessee Code|Title 68 - Health, Safety and Environmental Protection|Chapter 5 - Prevention of Diseases|Part 4 - Newborn Testing — Metabolic Defects|§ 68-5-402. Cooperation of Departments

 All state departments, including the department of human services, the department of mental health and substance abuse services, the department of intellectual and developmental disabilities, and county and municipal health departments and education departments, shall cooperate with the department in carrying out this part.
TN Code § 68-5-403 (2021)
2021 Tennessee Code|Title 68 - Health, Safety and Environmental Protection|Chapter 5 - Prevention of Diseases|Part 4 - Newborn Testing — Metabolic Defects|§ 68-5-403. Exemptions for Religious Beliefs

 Nothing in this part shall be construed to require the testing of or medical treatment for the minor child of any person who files with the department a signed, written statement that such tests or medical treatment conflict with the person's religious tenets and practices, affirmed under penalties of perjury.
TN Code § 68-5-404 (2021)
2021 Tennessee Code|Title 68 - Health, Safety and Environmental Protection|Chapter 5 - Prevention of Diseases|Part 4 - Newborn Testing — Metabolic Defects|§ 68-5-404. Failure to Have Child Tested — Misdemeanor

 Any person violating this part or parts of this chapter or the rules promulgated pursuant thereto, relative to testing of newborn infants, commits a Class C misdemeanor.
TN Code § 68-5-405 (2021)
2021 Tennessee Code|Title 68 - Health, Safety and Environmental Protection|Chapter 5 - Prevention of Diseases|Part 4 - Newborn Testing — Metabolic Defects|§ 68-5-405. Screening for Blood Glucose Abnormalities

 The department of health shall provide a link on the department's Internet web site to the web sites of the American Academy of Pediatrics and the American College of Obstetricians and Gynecologists for accessing the Guidelines for Perinatal Care regarding the indications for screening infants for blood glucose abnormalities. The board of medical examiners and the board of osteopathic examination shall publish the guidelines in the annual newsletter of each respective board.
TN Code § 68-5-406 (2021)
2021 Tennessee Code|Title 68 - Health, Safety and Environmental Protection|Chapter 5 - Prevention of Diseases|Part 4 - Newborn Testing — Metabolic Defects|§ 68-5-406. Retention of Newborn Screening Specimen — When Specimen and Form Containing Identifying Information Shall Be Destroyed — Retention of Specimen Beyond One Year

 A newborn screening specimen taken for testing pursuant to this part or part 5 of this chapter shall be kept for one (1) year to permit time for the infant's physician to request additional tests. After one (1) year, both the specimen and the form containing the identifying information shall be destroyed. If a specimen is needed for quality assessment, quality control, or test calibration, that specimen may be retained for longer than one (1) year; provided, that the form containing the identifying information has been separated from the sample and destroyed, to ensure that the source of the sample cannot be identified.
TN Code § 68-5-501 (2021)
2021 Tennessee Code|Title 68 - Health, Safety and Environmental Protection|Chapter 5 - Prevention of Diseases|Part 5 - Genetic Testing|§ 68-5-501. Definitions for Parts 4 and 5

 As used in parts 4 and 5 of this chapter, unless the context otherwise requires:   “Birth defects” means those abnormalities of body structure or function present at birth that adversely affect the intellectual capacity, health or abilities of affected individuals;   “Commissioner” means the commissioner of health or a designated representative;   “Committee” means the genetics advisory committee;   “Department” means the department of health;   “Genetic and metabolic screening” means search through systematic testing of the population at risk for metabolic or genetic conditions, to enable early dietary or medical treatment and counseling so as to ameliorate or avoid adverse consequences of those disorders; and   “Genetic disorders” means those conditions caused by an alteration or abnormality in the genetic material (DNA) which may adversely affect the health and functional abilities of affected individuals.
TN Code § 68-5-502 (2021)
2021 Tennessee Code|Title 68 - Health, Safety and Environmental Protection|Chapter 5 - Prevention of Diseases|Part 5 - Genetic Testing|§ 68-5-502. Establishment of Genetics Program

  The department shall establish a statewide genetics program to ensure the availability of genetic services to citizens of the state who need them for the prevention and treatment of intellectual disability or other physical dysfunctions.   The program shall include comprehensive genetic services programs, including genetic and metabolic screening programs, genetic counseling services, and other related services that will aid in the prevention and treatment of particular genetic disorders and birth defects or related conditions as determined by the department through rules and regulations duly promulgated in accordance with the Uniform Administrative Procedures Act, compiled in title 4, chapter 5, with the advice of the committee established in § 68-5-503.
TN Code § 68-5-503 (2021)
2021 Tennessee Code|Title 68 - Health, Safety and Environmental Protection|Chapter 5 - Prevention of Diseases|Part 5 - Genetic Testing|§ 68-5-503. Appointment of Advisory Committee — Terms — Travel

  The commissioner shall appoint a committee to consult with the department in the administration of parts 4 and 5 of this chapter.   The committee shall be composed of one (1) representative from each regional genetic and each regional sickle cell center established pursuant to parts 4 and 5 of this chapter; at least two (2) members at large; and the chief medical officer for the state.   The chief medical officer shall serve as chair of this committee.   Each member shall hold office for a term of four (4) years or until such member's successor is appointed, except for the terms of initial appointments which shall be set so as to have an equal number of terms expiring each successive year.   Any member appointed to fill a vacancy for any unexpired term shall serve the remainder of that term.   The committee shall meet as frequently as the commissioner deems necessary, but not less than once a year.   Committee members shall be reimbursed for travel expenses in accordance with the comprehensive travel regulations as promulgated by the department of finance and administration and approved by the attorney general and reporter.
TN Code § 68-5-505 (2021)
2021 Tennessee Code|Title 68 - Health, Safety and Environmental Protection|Chapter 5 - Prevention of Diseases|Part 5 - Genetic Testing|§ 68-5-505. Interstate Agreements

 The commissioner shall have the authority to formalize agreements with agencies in other states to provide services as may be needed.
TN Code § 68-5-507 (2021)
2021 Tennessee Code|Title 68 - Health, Safety and Environmental Protection|Chapter 5 - Prevention of Diseases|Part 5 - Genetic Testing|§ 68-5-507. Screening Program for Critical Cyanotic Congenital Heart Disease for Newborns

 On or before January 1, 2013, the genetic advisory committee is directed to develop a screening program for critical cyanotic congenital heart disease for the panel of screens authorized for newborns under § 68-5-504 that makes use of pulse oximetry.
TN Code § 68-5-508 (2021)
2021 Tennessee Code|Title 68 - Health, Safety and Environmental Protection|Chapter 5 - Prevention of Diseases|Part 5 - Genetic Testing|§ 68-5-508. Informational Pamphlets to Be Provided to Family Prior to Testing

 The information distributed to the family pursuant to §§ 68-5-504(b)(7) and 68-5-506(b)(3) shall be provided to the family before any blood sample for testing is drawn from the newborn. The pamphlet shall disclose the exemption from testing or treatment of a child pursuant to § 68-5-403. The pamphlet shall also inform the family of the newborn screening specimen use, retention, and disposal policy.
TN Code § 68-5-601 (2021)
2021 Tennessee Code|Title 68 - Health, Safety and Environmental Protection|Chapter 5 - Prevention of Diseases|Part 6 - Pregnancy Serological Tests|§ 68-5-601. Part Definitions

 As used in this part, unless the context otherwise requires:   “Approved laboratory” means a publicly or privately operated laboratory approved by the department according to its rules, governing the approval and licensing of laboratories for the purposes of this part;   “Commissioner” means the commissioner  of health or the commissioner's designee;   “Department” means the department of health;   “Forms” means the forms that are authorized, prepared and distributed by the department to carry out this part; and   “Standard serological test” means a test for syphilis infection or rubella immunity approved by the department and performed by an approved laboratory.
TN Code § 68-5-602 (2021)
2021 Tennessee Code|Title 68 - Health, Safety and Environmental Protection|Chapter 5 - Prevention of Diseases|Part 6 - Pregnancy Serological Tests|§ 68-5-602. When Required — Hepatitis B Treatment — Exception

  Every physician, surgeon, or other person permitted by law to attend a pregnant woman during gestation shall, in the case of each woman so attended, take or cause to be taken a sample of the blood of the woman at the time of first examination and visit or within ten (10) days after the first examination. If the first visit is at the time of delivery, or after delivery, the standard serological test required by this subsection (a) shall be performed at that time. The blood sample shall be sent to a laboratory approved by the department for testing for syphilis infection, rubella immunity, and hepatitis B surface antigen (HBsAg). In the same manner, a sample of blood shall be taken during or after the twenty-eighth week of gestation for a woman whom the attending physician determines to be at high risk of hepatitis B or syphilis according to the current standards of care. This second sample shall be sent to a laboratory approved by the department for testing for syphilis infection and HBsAg only. Additional testing for rubella immunity is not required in subsequent pregnancies once a positive result is verified or a documented history of vaccination against rubella is available. However, all pregnant women shall be tested for syphilis and hepatitis B during an early prenatal visit in each pregnancy. A positive test for syphilis and hepatitis B shall be reported to the local health department in accordance with this chapter, and regulations governing the control of communicable diseases in Tennessee.   Every person attending a pregnant woman who is not permitted by law to take blood samples shall cause a sample of blood to be taken by a health provider permitted by law to take the samples at the time of first examination and visit or within ten (10) days after the first examination. These samples shall be submitted to the same approved laboratories for testing for syphilis infection and HBsAg. If no rubella immunity is documented, testing for rubella is required.   Infants born to HBsAg-postive mothers shall receive, in a timely manner, the appropriate treatment as recognized by the centers for disease control.   This part shall not apply to any female who files with the attending medical authority a signed, written statement that taking a sample of blood or receiving other preventive measures conflict with the female's religious tenets and practices affirmed under the penalties of perjury.
TN Code § 68-5-603 (2021)
2021 Tennessee Code|Title 68 - Health, Safety and Environmental Protection|Chapter 5 - Prevention of Diseases|Part 6 - Pregnancy Serological Tests|§ 68-5-603. Testing Free of Charge — Authorized Laboratories

  Upon request, the laboratory tests required by this part shall be made without charge in the laboratories of the department.   This section shall not be interpreted to mean that the department's laboratories shall be the only laboratory approved to perform these tests.